Vifor Pharma Group has announced changes to its Executive Committee as current members Lee Heeson, President International, and Gregory Oakes, President North America, have decided to leave the company for personal reasons. Succession planning is currently underway and will be announced once the process has been concluded, according to a company statement.
In parallel to these management changes, Vifor Pharma has also announced that Molly Painter is joining the company as President U.S., effective as of 18 October 2021.
Abbas Hussain, Chief Executive Officer of Vifor Pharma Group, commented, “I am delighted to welcome Molly Painter to Vifor Pharma. She brings a wealth of experience with over 20 years in the healthcare industry. I want to thank Lee and Greg for their contributions to Vifor Pharma and to the Executive Committee, especially for their commitment and leadership of the organization during the COVID-19 pandemic. I wish them the very best for their future endeavours, both professionally and personally.”
Vifor Pharma Group is a global pharmaceuticals company. The company develops, manufactures and markets pharmaceutical products for precision patient care. Vifor Pharma Group holds a position in all its core business activities and consists of the following companies: Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care). Vifor Pharma Group is headquartered in Switzerland, and listed on the Swiss Stock Exchange
Arya has been a part of the Content & Research Team at Hrnxt.com. She is a keen observer of economic developments, emerging businesses, people in business and keeps a tab on latest happenings in the business environment.